Quality & complianceOfficial

DKMA flags Paracox-8 Vet. supply problems, citing higher demand for MSD Animal Health vaccine

🇩🇰 DKMA · Wed 04 Nov 2026

Denmark's medicines agency says supply of Paracox-8 Vet. oral suspension is disrupted, with increased sales and demand given as the cause.

The Danish Medicines Agency (DKMA) has published a supply notice for Paracox-8 Vet., an oral suspension from MSD Animal Health A/S. The agency says there are current problems with supply of the veterinary product.

The notice gives the cause as increased sales and demand. The expected period of disruption is mid-October to the start of November 2026. The notice itself is dated 4 November 2026.

The product is a vaccine containing Eimeria strains: brunetti HP, maxima MFP and CP, acervulina HP, mitis HP, necatrix HP, praecox HP and tenella HP. Its ATC code is QI01AN01.

The notice does not name alternative products or set out any mitigation measures. DKMA directs questions about the current status to MSD Animal Health, and it lists the notice on its page for supply-of-medicines announcements.

What it means for your team

  • Supply-chain and QA teams with Danish exposure should ask MSD Animal Health directly for the current status, as DKMA advises.
  • The stated window (mid-October to early November 2026) is an expectation, and the notice does not say whether supply has resumed. Watch DKMA's supply announcements for updates.
  • The cause is demand-driven rather than quality-related. The notice does not mention a recall or a product defect.

Official source: DKMA ↗

Article written by VigiEye from the official source (DKMA). AI-assisted; check the source before acting.

More Quality & compliance All →